 | | XY8 | | Name: | 3-{4-[(2,4-difluorophenyl)methyl]piperazin-1-yl}-7-methyl-N-(propan-2-yl)pyrido[3,4-b]pyrazin-2-amine | | Formula: | C22 H26 F2 N6 | | SMILES: | CC(C)Nc1nc2cc(C)ncc2nc1N1CCN(Cc2ccc(F)cc2F)CC1 | | InChi: | InChI=1S/C22H26F2N6/c1-14(2)26-21-22(28-20-12-25-15(3)10-19(20)27-21)30-8-6-29(7-9-30)13-16-4-5-17(23)11-18(16)24/h4-5,10-12,14H,6-9,13H2,1-3H3,(H,26,27) | | Definition date: | 2023-06-05 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 3-{4-[(2,4-difluorophenyl)methyl]piperazin-1-yl}-7-methyl-N-(propan-2-yl)pyrido[3,4-b]pyrazin-2-amine |
|
 | | X5U | | Name: | (S)-alpha-methyl-4-Iodophenylalanine | | Formula: | C10 H12 I N O2 | | SMILES: | C[C](N)(Cc1ccc(I)cc1)C(O)=O | | InChi: | InChI=1S/C10H12INO2/c1-10(12,9(13)14)6-7-2-4-8(11)5-3-7/h2-5H,6,12H2,1H3,(H,13,14)/t10-/m0/s1 | | Synonyms: | (2S)-2-azanyl-3-(4-iodophenyl)-2-methyl-propanoic acid | | Definition date: | 2023-10-23 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (2~{S})-2-azanyl-3-(4-iodophenyl)-2-methyl-propanoic acid |
|
 | | X7T | | Name: | 1-{2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-3-{[(3R)-oxolan-3-yl]amino}-7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl}ethan-1-one | | Formula: | C24 H29 F2 N5 O3 | | SMILES: | Fc1ccc(OC2CCN(CC2)c2nc3CCN(Cc3nc2NC2CCOC2)C(C)=O)c(F)c1 | | InChi: | InChI=1S/C24H29F2N5O3/c1-15(32)31-10-6-20-21(13-31)28-23(27-17-7-11-33-14-17)24(29-20)30-8-4-18(5-9-30)34-22-3-2-16(25)12-19(22)26/h2-3,12,17-18H,4-11,13-14H2,1H3,(H,27,28)/t17-/m1/s1 | | Definition date: | 2023-06-05 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 1-{2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-3-{[(3R)-oxolan-3-yl]amino}-7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl}ethan-1-one |
|
 | | IB0 | | Name: | (7-methyl-2,3-dihydroindol-1-yl)-(1,2,3-triazol-1-yl)methanone | | Formula: | C12 H12 N4 O | | SMILES: | Cc1cccc2CCN(C(=O)n3ccnn3)c12 | | InChi: | InChI=1S/C12H12N4O/c1-9-3-2-4-10-5-7-15(11(9)10)12(17)16-8-6-13-14-16/h2-4,6,8H,5,7H2,1H3 | | Definition date: | 2022-06-24 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (7-methyl-2,3-dihydroindol-1-yl)-(1,2,3-triazol-1-yl)methanone |
|
 | | K0O | | Name: | Aspterric Acid | | Formula: | C15 H22 O4 | | SMILES: | CC(C)=C1CC[C]23CO[CH](C2)[C](O)(CC[CH]13)C(O)=O | | InChi: | InChI=1S/C15H22O4/c1-9(2)10-3-5-14-7-12(19-8-14)15(18,13(16)17)6-4-11(10)14/h11-12,18H,3-8H2,1-2H3,(H,16,17)/t11-,12+,14+,15+/m0/s1 | | Synonyms: | (1~{S},5~{S},8~{R},9~{R})-8-oxidanyl-4-propan-2-ylidene-10-oxatricyclo[7.2.1.0^{1,5}]dodecane-8-carboxylic acid | | Definition date: | 2022-09-02 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (1~{S},5~{S},8~{R},9~{R})-8-oxidanyl-4-propan-2-ylidene-10-oxatricyclo[7.2.1.0^{1,5}]dodecane-8-carboxylic acid |
|
 | | A1AQR | | Name: | (1S,3S)-N-[6-bromo-5-(pyrimidin-2-yl)pyridin-2-yl]-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxamide | | Formula: | C19 H21 Br N4 O | | SMILES: | CC(C)=C/C1C(C(=O)Nc2nc(Br)c(cc2)c2ncccn2)C1(C)C | | InChi: | InChI=1S/C19H21BrN4O/c1-11(2)10-13-15(19(13,3)4)18(25)24-14-7-6-12(16(20)23-14)17-21-8-5-9-22-17/h5-10,13,15H,1-4H3,(H,23,24,25)/t13-,15+/m0/s1 | | Definition date: | 2024-05-01 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (1S,3S)-N-[6-bromo-5-(pyrimidin-2-yl)pyridin-2-yl]-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxamide |
|
 | | A1BH8 | | Name: | 4-({(ethanesulfonyl)[(pyridin-3-yl)methyl]amino}methyl)-N-hydroxybenzamide | | Formula: | C16 H19 N3 O4 S | | SMILES: | ONC(=O)c1ccc(cc1)CN(Cc1cccnc1)S(=O)(=O)CC | | InChi: | InChI=1S/C16H19N3O4S/c1-2-24(22,23)19(12-14-4-3-9-17-10-14)11-13-5-7-15(8-6-13)16(20)18-21/h3-10,21H,2,11-12H2,1H3,(H,18,20) | | Definition date: | 2024-11-22 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 4-({(ethanesulfonyl)[(pyridin-3-yl)methyl]amino}methyl)-N-hydroxybenzamide |
|
 | | A1BH9 | | Name: | N-hydroxy-4-({[(pyridin-3-yl)methyl](thiophene-3-sulfonyl)amino}methyl)benzamide | | Formula: | C18 H17 N3 O4 S2 | | SMILES: | O=S(=O)(N(Cc1ccc(cc1)C(=O)NO)Cc1cccnc1)c1ccsc1 | | InChi: | InChI=1S/C18H17N3O4S2/c22-18(20-23)16-5-3-14(4-6-16)11-21(12-15-2-1-8-19-10-15)27(24,25)17-7-9-26-13-17/h1-10,13,23H,11-12H2,(H,20,22) | | Definition date: | 2024-11-22 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | N-hydroxy-4-({[(pyridin-3-yl)methyl](thiophene-3-sulfonyl)amino}methyl)benzamide |
|
 | | A1BHX | | Name: | N-hydroxy-4-({(propane-2-sulfonyl)[(pyridin-3-yl)methyl]amino}methyl)benzamide | | Formula: | C17 H21 N3 O4 S | | SMILES: | ONC(=O)c1ccc(cc1)CN(Cc1cccnc1)S(=O)(=O)C(C)C | | InChi: | InChI=1S/C17H21N3O4S/c1-13(2)25(23,24)20(12-15-4-3-9-18-10-15)11-14-5-7-16(8-6-14)17(21)19-22/h3-10,13,22H,11-12H2,1-2H3,(H,19,21) | | Definition date: | 2024-11-21 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | N-hydroxy-4-({(propane-2-sulfonyl)[(pyridin-3-yl)methyl]amino}methyl)benzamide |
|
 | | A1BHY | | Name: | N-hydroxy-4-({(methanesulfonyl)[(pyridin-3-yl)methyl]amino}methyl)benzamide | | Formula: | C15 H17 N3 O4 S | | SMILES: | ONC(=O)c1ccc(cc1)CN(Cc1cccnc1)S(C)(=O)=O | | InChi: | InChI=1S/C15H17N3O4S/c1-23(21,22)18(11-13-3-2-8-16-9-13)10-12-4-6-14(7-5-12)15(19)17-20/h2-9,20H,10-11H2,1H3,(H,17,19) | | Definition date: | 2024-11-21 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | N-hydroxy-4-({(methanesulfonyl)[(pyridin-3-yl)methyl]amino}methyl)benzamide |
|
 | | A1D5Q | | Name: | [(2~{R})-1-hexadecanoyloxy-3-[oxidanyl-[(2~{S},3~{R},5~{R},6~{S})-2,3,4,5,6-pentakis(oxidanyl)cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] (~{Z})-octadec-9-enoate | | Formula: | C43 H81 O13 P | | SMILES: | CCCCCCCCCCCCCCCC(=O)OC[CH](CO[P](O)(=O)O[CH]1[CH](O)[CH](O)[CH](O)[CH](O)[CH]1O)OC(=O)CCCCCCCC=CCCCCCCCC | | InChi: | InChI=1S/C43H81O13P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(45)55-35(34-54-57(51,52)56-43-41(49)39(47)38(46)40(48)42(43)50)33-53-36(44)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,35,38-43,46-50H,3-16,19-34H2,1-2H3,(H,51,52)/b18-17-/t35-,38-,39-,40-,41+,42+,43+/m1/s1 | | Definition date: | 2024-01-30 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | [(2~{R})-1-hexadecanoyloxy-3-[oxidanyl-[(2~{S},3~{R},5~{R},6~{S})-2,3,4,5,6-pentakis(oxidanyl)cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] (~{Z})-octadec-9-enoate |
|
 | | A1EAG | | Name: | 8-oxa-2-azaspiro[4.5]decan-2-yl-[2-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1,3-thiazol-5-yl]methanone | | Formula: | C16 H23 N3 O3 S | | SMILES: | O[CH]1CCN(C1)c2sc(cn2)C(=O)N3CCC4(CCOCC4)C3 | | InChi: | InChI=1S/C16H23N3O3S/c20-12-1-5-18(10-12)15-17-9-13(23-15)14(21)19-6-2-16(11-19)3-7-22-8-4-16/h9,12,20H,1-8,10-11H2/t12-/m0/s1 | | Definition date: | 2024-08-08 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 8-oxa-2-azaspiro[4.5]decan-2-yl-[2-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1,3-thiazol-5-yl]methanone |
|
 | | A1EAU | | Name: | ~{N}2,~{N}6-bis[2-[2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyethoxy]ethyl]naphthalene-2,6-dicarboxamide | | Formula: | C32 H46 N2 O16 | | SMILES: | OC[CH]1O[CH](OCCOCCNC(=O)c2ccc3cc(ccc3c2)C(=O)NCCOCCO[CH]4O[CH](CO)[CH](O)[CH](O)[CH]4O)[CH](O)[CH](O)[CH]1O | | InChi: | InChI=1S/C32H46N2O16/c35-15-21-23(37)25(39)27(41)31(49-21)47-11-9-45-7-5-33-29(43)19-3-1-17-13-20(4-2-18(17)14-19)30(44)34-6-8-46-10-12-48-32-28(42)26(40)24(38)22(16-36)50-32/h1-4,13-14,21-28,31-32,35-42H,5-12,15-16H2,(H,33,43)(H,34,44)/t21-,22-,23-,24-,25+,26+,27+,28+,31+,32+/m1/s1 | | Definition date: | 2024-08-19 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | ~{N}2,~{N}6-bis[2-[2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyethoxy]ethyl]naphthalene-2,6-dicarboxamide |
|
 | | A1EAV | | Name: | 1,10-phenanthroline-2,9-dicarboxylic acid | | Formula: | C14 H8 N2 O4 | | SMILES: | OC(=O)c1ccc2ccc3ccc(nc3c2n1)C(O)=O | | InChi: | InChI=1S/C14H8N2O4/c17-13(18)9-5-3-7-1-2-8-4-6-10(14(19)20)16-12(8)11(7)15-9/h1-6H,(H,17,18)(H,19,20) | | Definition date: | 2024-08-19 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 1,10-phenanthroline-2,9-dicarboxylic acid |
|
 | | A1EAW | | Name: | ~{N}2,~{N}9-bis[2-[2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyethoxy]ethyl]-1,10-phenanthroline-2,9-dicarboxamide | | Formula: | C34 H46 N4 O16 | | SMILES: | OC[CH]1O[CH](OCCOCCNC(=O)c2ccc3ccc4ccc(nc4c3n2)C(=O)NCCOCCO[CH]5O[CH](CO)[CH](O)[CH](O)[CH]5O)[CH](O)[CH](O)[CH]1O | | InChi: | InChI=1S/C34H46N4O16/c39-15-21-25(41)27(43)29(45)33(53-21)51-13-11-49-9-7-35-31(47)19-5-3-17-1-2-18-4-6-20(38-24(18)23(17)37-19)32(48)36-8-10-50-12-14-52-34-30(46)28(44)26(42)22(16-40)54-34/h1-6,21-22,25-30,33-34,39-46H,7-16H2,(H,35,47)(H,36,48)/t21-,22-,25-,26-,27+,28+,29+,30+,33+,34+/m1/s1 | | Synonyms: | 1,6-DI-O-PHOSPHONO-D-MANNITOL | | Definition date: | 2024-08-19 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | ~{N}2,~{N}9-bis[2-[2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyethoxy]ethyl]-1,10-phenanthroline-2,9-dicarboxamide |
|
 | | A1ACA | | Name: | 5-[(5-bromo-2-chloropyrimidin-4-yl)amino]-1,3-dihydro-2H-indol-2-one | | Formula: | C12 H8 Br Cl N4 O | | SMILES: | Brc1cnc(Cl)nc1Nc1cc2CC(=O)Nc2cc1 | | InChi: | InChI=1S/C12H8BrClN4O/c13-8-5-15-12(14)18-11(8)16-7-1-2-9-6(3-7)4-10(19)17-9/h1-3,5H,4H2,(H,17,19)(H,15,16,18) | | Definition date: | 2024-01-09 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 5-[(5-bromo-2-chloropyrimidin-4-yl)amino]-1,3-dihydro-2H-indol-2-one |
|
 | | A1ACV | | Name: | (1r,4r)-N~1~-[(7P)-2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl]cyclohexane-1,4-diamine | | Formula: | C25 H27 N9 | | SMILES: | Cn1nc(nn1)c1cc2[NH]c3nc(Cc4ccccc4)nc(NC4CCC(N)CC4)c3c2cc1 | | InChi: | InChI=1S/C25H27N9/c1-34-32-23(31-33-34)16-7-12-19-20(14-16)28-25-22(19)24(27-18-10-8-17(26)9-11-18)29-21(30-25)13-15-5-3-2-4-6-15/h2-7,12,14,17-18H,8-11,13,26H2,1H3,(H2,27,28,29,30)/t17-,18- | | Definition date: | 2024-01-16 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (1r,4r)-N~1~-[(7P)-2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl]cyclohexane-1,4-diamine |
|
 | | A1H0A | | Name: | 4-[(2~{R},4~{R})-4-azanyl-2-carboxy-pyrrolidin-2-yl]butyl-tris(oxidanyl)boranuide | | Formula: | C9 H20 B N2 O5 | | SMILES: | N[CH]1CN[C](CCCC[B-](O)(O)O)(C1)C(O)=O | | InChi: | InChI=1S/C9H20BN2O5/c11-7-5-9(8(13)14,12-6-7)3-1-2-4-10(15,16)17/h7,12,15-17H,1-6,11H2,(H,13,14)/q-1/t7-,9-/m1/s1 | | Definition date: | 2023-12-14 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 4-[(2~{R},4~{R})-4-azanyl-2-carboxy-pyrrolidin-2-yl]butyl-tris(oxidanyl)boranuide |
|
 | | A1H0B | | Name: | (2~{S},3~{R})-3-[3-(dihydroxyboranyl)propyl]pyrrolidine-2-carboxylic acid | | Formula: | C8 H16 B N O4 | | SMILES: | OB(O)CCC[CH]1CCN[CH]1C(O)=O | | InChi: | InChI=1S/C8H16BNO4/c11-8(12)7-6(3-5-10-7)2-1-4-9(13)14/h6-7,10,13-14H,1-5H2,(H,11,12)/t6-,7+/m1/s1 | | Definition date: | 2023-12-14 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (2~{S},3~{R})-3-[3-(dihydroxyboranyl)propyl]pyrrolidine-2-carboxylic acid |
|
 | | A1H8P | | Name: | 7-bromanyl-3~{H}-imidazo[4,5-b]pyridine | | Formula: | C6 H4 Br N3 | | SMILES: | Brc1ccnc2[nH]cnc12 | | InChi: | InChI=1S/C6H4BrN3/c7-4-1-2-8-6-5(4)9-3-10-6/h1-3H,(H,8,9,10) | | Definition date: | 2024-04-18 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 7-bromanyl-3~{H}-imidazo[4,5-b]pyridine |
|
 | | A1IED | | Name: | 6-[5-[6-(4-oxidanylcyclohexyl)oxy-1~{H}-pyrrolo[2,3-b]pyridin-5-yl]-1,2-oxazol-3-yl]pyridine-2-carboxamide | | Formula: | C22 H21 N5 O4 | | SMILES: | NC(=O)c1cccc(n1)c2cc(on2)c3cc4cc[nH]c4nc3O[CH]5CC[CH](O)CC5 | | InChi: | InChI=1S/C22H21N5O4/c23-20(29)17-3-1-2-16(25-17)18-11-19(31-27-18)15-10-12-8-9-24-21(12)26-22(15)30-14-6-4-13(28)5-7-14/h1-3,8-11,13-14,28H,4-7H2,(H2,23,29)(H,24,26) | | Definition date: | 2024-06-13 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 6-[5-[6-(4-oxidanylcyclohexyl)oxy-1~{H}-pyrrolo[2,3-b]pyridin-5-yl]-1,2-oxazol-3-yl]pyridine-2-carboxamide |
|
 | | A1IKY | | Name: | ~{N}-[6-(oxidanylamino)-6-oxidanylidene-hexoxy]-4-(4-pyrrolidin-1-ylphenyl)-1,3-thiazolidine-2-carboxamide | | Formula: | C20 H26 N4 O4 S | | SMILES: | ONC(=O)CCCCCONC(=O)c1scc(n1)c2ccc(cc2)N3CCCC3 | | InChi: | InChI=1S/C20H26N4O4S/c25-18(22-27)6-2-1-5-13-28-23-19(26)20-21-17(14-29-20)15-7-9-16(10-8-15)24-11-3-4-12-24/h7-10,14,27H,1-6,11-13H2,(H,22,25)(H,23,26) | | Definition date: | 2024-08-14 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | ~{N}-[6-(oxidanylamino)-6-oxidanylidene-hexoxy]-4-(4-pyrrolidin-1-ylphenyl)-1,3-thiazole-2-carboxamide |
|
 | | A1IMY | | Name: | (1S,3S,4S)-N-[(2S)-1-azanylidene-3-[(3S)-5,5-dimethyl-2-oxidanylidene-pyrrolidin-3-yl]propan-2-yl]-2-[(2R)-3-cyclobutyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]propanoyl]-5,5-bis(fluoranyl)-2-azabicyclo[2.2.2]octane-3-carboxamide | | Formula: | C26 H36 F5 N5 O4 | | SMILES: | CC1(C)C[CH](C[CH](NC(=O)[CH]2[CH]3CC[CH](CC3(F)F)N2C(=O)[CH](CC4CCC4)NC(=O)C(F)(F)F)C=N)C(=O)N1 | | InChi: | InChI=1S/C26H36F5N5O4/c1-24(2)10-14(20(37)35-24)9-15(12-32)33-21(38)19-17-7-6-16(11-25(17,27)28)36(19)22(39)18(8-13-4-3-5-13)34-23(40)26(29,30)31/h12-19,32H,3-11H2,1-2H3,(H,33,38)(H,34,40)(H,35,37)/t14-,15-,16-,17-,18+,19-/m0/s1 | | Definition date: | 2024-08-28 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (1~{S},3~{S},4~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-5,5-dimethyl-2-oxidanylidene-pyrrolidin-3-yl]propan-2-yl]-2-[(2~{R})-3-cyclobutyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]propanoyl]-5,5-bis(fluoranyl)-2-azabicyclo[2.2.2]octane-3-carboxamide |
|
 | | A1IO1 | | Name: | (3~{S})-3-azanyl-4-[(3~{R},4~{R},6~{S})-3-[1,3-dimethyl-2,6-bis(oxidanylidene)purin-7-yl]-4-methyl-4,6-bis(oxidanyl)azepan-1-yl]-4-oxidanylidene-butanoic acid | | Formula: | C18 H26 N6 O7 | | SMILES: | CN1C(=O)N(C)c2ncn([CH]3CN(C[CH](O)C[C]3(C)O)C(=O)[CH](N)CC(O)=O)c2C1=O | | InChi: | InChI=1S/C18H26N6O7/c1-18(31)5-9(25)6-23(15(28)10(19)4-12(26)27)7-11(18)24-8-20-14-13(24)16(29)22(3)17(30)21(14)2/h8-11,25,31H,4-7,19H2,1-3H3,(H,26,27)/t9-,10-,11+,18+/m0/s1 | | Definition date: | 2024-09-19 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | (3~{S})-3-azanyl-4-[(3~{R},4~{R},6~{S})-3-[1,3-dimethyl-2,6-bis(oxidanylidene)purin-7-yl]-4-methyl-4,6-bis(oxidanyl)azepan-1-yl]-4-oxidanylidene-butanoic acid |
|
 | | A1ISA | | Name: | 5-ethyl-2-[(2-methoxyphenyl)amino]-8-phenyl-pyrido[2,3-d]pyrimidin-7-one | | Formula: | C22 H20 N4 O2 | | SMILES: | CCC1=CC(=O)N(c2ccccc2)c3nc(Nc4ccccc4OC)ncc13 | | InChi: | InChI=1S/C22H20N4O2/c1-3-15-13-20(27)26(16-9-5-4-6-10-16)21-17(15)14-23-22(25-21)24-18-11-7-8-12-19(18)28-2/h4-14H,3H2,1-2H3,(H,23,24,25) | | Definition date: | 2024-10-23 | | Last modified: | 2024-11-29 | | Release date: | 2024-12-04 | | Identifier: | 5-ethyl-2-[(2-methoxyphenyl)amino]-8-phenyl-pyrido[2,3-d]pyrimidin-7-one |
|
